Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1961 1
1965 1
1972 1
1974 1
1975 1
1977 2
1980 2
1982 3
1983 3
1984 4
1985 3
1986 4
1987 7
1988 5
1989 6
1990 5
1991 9
1992 8
1993 15
1994 12
1995 16
1996 12
1997 27
1998 19
1999 18
2000 25
2001 48
2002 47
2003 68
2004 79
2005 76
2006 121
2007 128
2008 145
2009 172
2010 176
2011 218
2012 271
2013 321
2014 331
2015 383
2016 371
2017 409
2018 472
2019 526
2020 584
2021 693
2022 829
2023 807
2024 900
2025 978
2026 588

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,936 results

Results by year

Filters applied: . Clear all
Page 1
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.
Rodriguez GE, Zhao Y, Nishiga Y, Peprah F, Shen J, Abhiraman GC, Ogishi M, Zhang C, Saco J, Waghray D, Serasanambati M, Torres L, Simone BW, Su L, Wilson SC, Yang A, Sun Q, Picton L, Saxton RA, Bhandarkar V, Lee MJ, Andrews E, Jiang H, Obenaus M, Yen M, Atajanova T, Blish CA, Spranger S, Wherry EJ, Kirane A, Ribas A, Raulet DH, Kalbasi A, Dougan SK, Dougan M, Sage J, Garcia KC. Rodriguez GE, et al. Among authors: su l. Science. 2026 May 14;392(6799):eadx9954. doi: 10.1126/science.adx9954. Epub 2026 May 14. Science. 2026. PMID: 41712697 Free PMC article.
Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling.
Xu Z, Wang H, Yu J, Deng Y, Tian X, Ni R, Xia F, Yang L, Xu C, Zhang L, Luo R, Chen P, Zhang X, Liu Y, Hou J, Zhang M, Chen S, Su L, Sun H, He Y, Chen D, Chen X, Miao Z, Xie J, Liu X, Zhao J, Ke B, Tian X, Zeng L, Zhang L, Tang X, Yang S, Liu J, Wang X, Yan W, Shao Z. Xu Z, et al. Among authors: su l. Nature. 2026 Mar;651(8106):829-837. doi: 10.1038/s41586-025-10061-7. Epub 2026 Jan 28. Nature. 2026. PMID: 41606342
Low-input deep learning platform for citrullinated peptide identification, autoantigen discovery and rheumatoid arthritis treatment stratification.
Hu M, Zhu C, Sun R, Xu Z, Gong Y, Liu Y, Liu Y, Xu J, Hu H, Chen T, Zhang M, Zou Q, Yang P, Zou J, Su L, Tan W, Meng L, Herrmann M, Muñoz LE, Feng S, Lin T, Xu H, Ying B, Peng Y, Gjertsson I, Holmdahl R, Zhao Y, Dai L. Hu M, et al. Among authors: su l. Nat Biomed Eng. 2026 Mar 3. doi: 10.1038/s41551-026-01628-4. Online ahead of print. Nat Biomed Eng. 2026. PMID: 41776034
High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemia.
Dotti G, Walhart T, Biondi M, Stucchi S Sr, Li G, Tsahouridis O, Shou P, Suzuki K, Hunt EG, Kennedy A, Thaxton J, Withers T, Herring L, Elliott CG, Hunsucker SA, Serafini M, Flick L, Lichtman EI, Woodcock MG, Su L, Yang Z, Xiong G, Cui Z, Wang P, Liu C, Savoldo B, Armistead PM, Song F. Dotti G, et al. Among authors: su l. Blood. 2026 Mar 12:blood.2025030577. doi: 10.1182/blood.2025030577. Online ahead of print. Blood. 2026. PMID: 42247309
Publisher Correction: Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling.
Xu Z, Wang H, Yu J, Deng Y, Tian X, Ni R, Xia F, Yang L, Xu C, Zhang L, Luo R, Chen P, Zhang X, Liu Y, Hou J, Zhang M, Chen S, Su L, Sun H, He Y, Chen D, Chen X, Miao Z, Xie J, Liu X, Zhao J, Ke B, Tian X, Zeng L, Zhang L, Tang X, Yang S, Liu J, Wang X, Yan W, Shao Z. Xu Z, et al. Among authors: su l. Nature. 2026 Mar;651(8104):E5. doi: 10.1038/s41586-026-10249-5. Nature. 2026. PMID: 41703299 No abstract available.
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial.
Xu PP, Song YQ, Shen JZ, Cai QQ, Zhou H, Zhang LL, Xiang Y, Sun XH, Yang W, Yao ZH, Jing HM, Wen SJ, Jin J, Xue HW, Cen H, Ding KY, Jin ZM, Liu LH, Xing XJ, Li LF, Hou M, Liu L, Zhang MZ, Li WY, Bai O, Feng R, Zhu ZM, Wu HJ, Su LP, Gao L, Li F, Huang WR, Liu P, Yan XJ, Zhao Y, Su H, Zhao XL, Fu R, Liu H, Shi WY, Li HZ, Chen B, Ning ZQ, Zhu J, Zhao WL. Xu PP, et al. Among authors: su lp. JAMA. 2026 May 19;335(19):1684-1693. doi: 10.1001/jama.2026.4199. JAMA. 2026. PMID: 42018318 Clinical Trial.
8,936 results